Literature DB >> 9166339

Uterine rupture during induction of labor at term with intravaginal misoprostol.

B B Bennett1.   

Abstract

BACKGROUND: Misoprostol (prostaglandin E1) compares favorably with dinoprostone (prostaglandin E2) and oxytocin for labor induction at term. Excessive uterine activity has been reported using high-dose regimens, but no negative effect on outcomes has been observed. CASE: Labor was induced in a 34-year-old multipara at 39 weeks' gestation using intravaginal misoprostol tablets. Five hours after administration of the second 25-microgram dose, fetal bradycardia prompted emergency cesarean delivery. Hysterectomy and left salpingo-oophorectomy were necessary to control bleeding from a 15-cm posterior uterine wall rupture.
CONCLUSION: Misoprostol can cause excessive uterine activity and uterine rupture.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166339     DOI: 10.1016/s0029-7844(97)00036-7

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

Review 1.  Vaginal misoprostol for cervical ripening and induction of labour.

Authors:  G Justus Hofmeyr; A Metin Gülmezoglu; Cynthia Pileggi
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

2.  Elective induction versus spontaneous labour in Latin America.

Authors:  Gláucia Virgínia Guerra; José Guilherme Cecatti; João Paulo Souza; Aníbal Faúndes; Sirlei Siani Morais; Ahmet Metin Gülmezoglu; Renato Passini; Mary Angela Parpinelli; Guillermo Carroli
Journal:  Bull World Health Organ       Date:  2011-07-05       Impact factor: 9.408

Review 3.  Misoprostol for Labour Induction after Previous Caesarean Section - Forever a "No Go"?

Authors:  W Rath; P Tsikouras
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

Review 4.  Methods of term labour induction for women with a previous caesarean section.

Authors:  Helen M West; Marta Jozwiak; Jodie M Dodd
Journal:  Cochrane Database Syst Rev       Date:  2017-06-09

Review 5.  A benefit-risk assessment of misoprostol for cervical ripening and labour induction.

Authors:  Deborah A Wing
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Quality assessment of patient leaflets on misoprostol-induced labour: does written information adhere to international standards for patient involvement and informed consent?

Authors:  Jette Aaroe Clausen; Mette Juhl; Eva Rydahl
Journal:  BMJ Open       Date:  2016-05-27       Impact factor: 2.692

Review 7.  A critical appraisal of the misoprostol removable, controlled-release vaginal delivery system of labor induction.

Authors:  Charlotte Patte; Philippe Deruelle
Journal:  Int J Womens Health       Date:  2015-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.